PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Kamada (KMDA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

IL0010941198

CUSIP

M6240T109

Sector

Healthcare

IPO Date

May 31, 2013

Highlights

Market Cap

$450.16M

EPS (TTM)

$0.27

PE Ratio

29.00

PEG Ratio

8.75

Total Revenue (TTM)

$121.35M

Gross Profit (TTM)

$52.67M

EBITDA (TTM)

$16.23M

Year Range

$4.74 - $9.16

Target Price

$14.25

Short %

0.03%

Short Ratio

0.05

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Kamada, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
41.34%
9.31%
KMDA (Kamada)
Benchmark (^GSPC)

Returns By Period

Kamada had a return of 28.57% year-to-date (YTD) and 29.31% in the last 12 months. Over the past 10 years, Kamada had an annualized return of 5.63%, while the S&P 500 had an annualized return of 11.31%, indicating that Kamada did not perform as well as the benchmark.


KMDA

YTD

28.57%

1M

9.36%

6M

41.34%

1Y

29.31%

5Y*

5.39%

10Y*

5.63%

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of KMDA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202510.51%28.57%
2024-6.37%9.95%-10.95%-6.95%0.96%-5.88%13.91%1.77%-6.61%6.89%2.61%3.40%-0.49%
202316.71%-7.69%7.52%0.32%3.65%9.21%-6.54%16.63%-7.13%-20.79%11.82%29.39%52.62%
2022-8.05%-8.26%-0.54%-2.72%-16.01%-0.00%13.75%-2.73%-9.62%-0.00%4.21%-14.68%-39.06%
2021-0.15%-5.10%0.81%-2.58%-2.65%-0.85%-6.53%-1.10%-1.49%7.74%9.11%5.62%1.54%
2020-4.83%-10.63%0.36%28.64%4.67%-1.15%14.18%11.96%-15.73%-14.47%-5.17%-4.42%-5.12%
20195.00%17.52%-7.13%0.17%-5.05%1.28%2.72%-1.06%-8.56%1.95%42.07%-8.08%36.60%
201814.74%-3.67%-12.38%3.26%6.32%2.97%10.58%3.48%4.20%-14.52%-1.51%-4.22%5.26%
201714.56%11.32%-2.16%5.15%-1.40%-14.89%-20.83%-5.26%6.67%4.17%-6.50%1.60%-12.84%
2016-10.76%-4.32%8.10%2.70%-6.87%0.27%7.90%21.72%6.43%12.09%-3.48%-1.80%31.45%
20156.05%11.91%-2.00%-2.26%5.56%-16.23%0.79%-9.61%-1.72%16.96%5.75%-1.99%9.11%
20141.55%14.83%-16.38%-1.31%-44.03%-10.99%-2.38%-1.29%-35.08%-7.06%-23.04%19.12%-74.45%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of KMDA is 65, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of KMDA is 6565
Overall Rank
The Sharpe Ratio Rank of KMDA is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of KMDA is 6666
Sortino Ratio Rank
The Omega Ratio Rank of KMDA is 6262
Omega Ratio Rank
The Calmar Ratio Rank of KMDA is 6363
Calmar Ratio Rank
The Martin Ratio Rank of KMDA is 6666
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Kamada (KMDA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for KMDA, currently valued at 0.72, compared to the broader market-2.000.002.000.721.74
The chart of Sortino ratio for KMDA, currently valued at 1.32, compared to the broader market-4.00-2.000.002.004.006.001.322.35
The chart of Omega ratio for KMDA, currently valued at 1.15, compared to the broader market0.501.001.502.001.151.32
The chart of Calmar ratio for KMDA, currently valued at 0.38, compared to the broader market0.002.004.006.000.382.61
The chart of Martin ratio for KMDA, currently valued at 2.04, compared to the broader market0.0010.0020.0030.002.0410.66
KMDA
^GSPC

The current Kamada Sharpe ratio is 0.72. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Kamada with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.72
1.74
KMDA (Kamada)
Benchmark (^GSPC)

Dividends

Dividend History


Kamada doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-55.26%
0
KMDA (Kamada)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Kamada. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Kamada was 82.46%, occurring on Nov 25, 2014. The portfolio has not yet recovered.

The current Kamada drawdown is 55.26%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-82.46%Mar 6, 2014185Nov 25, 2014
-16.52%Oct 15, 201312Oct 30, 201354Jan 17, 201466
-12.82%Jan 23, 20146Jan 30, 201419Feb 27, 201425
-8.3%Aug 7, 201315Aug 27, 201310Sep 11, 201325
-6.83%Jun 4, 20133Jun 6, 20134Jun 12, 20137

Volatility

Volatility Chart

The current Kamada volatility is 17.81%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
17.81%
3.07%
KMDA (Kamada)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Kamada over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Kamada compared to its peers in the Drug Manufacturers - Specialty & Generic industry.


PE Ratio
20.040.060.080.029.0
The chart displays the price to earnings (P/E) ratio for KMDA in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, KMDA has a PE value of 29.0. This PE ratio falls in the average range for the industry.
PEG Ratio
-150.0-100.0-50.00.08.8
The chart displays the price to earnings to growth (PEG) ratio for KMDA in comparison to other companies of the Drug Manufacturers - Specialty & Generic industry. Currently, KMDA has a PEG value of 8.8. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Kamada.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab